Publication | Closed Access

First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study

MedicineBronchial NeoplasmAdvanced AlkFirst-line CeritinibCancer TreatmentOncologyRadiation OncologyLung CancerMolecular OncologyRadiologyHealth Sciences